Professor P-O Berggren and his research groups run an impressive list of scientific projects outside those commercialized by Biocrine. The research groups also participate in projects conducted by other groups. In most cases, all these projects result in successful scientific publications. Here is a list of publications generated since 2013: β-cell-targeted RNA activation of vascular endothelial …
As has recently been published on the Karolinska Institutet in Sweden’s website, reasearchers led by professor Per-Olof Berggren and his colleagues have developed a targeted RNA technology to prepare pancreatic islet cells for transplantation. The findings have been published in Signal Transduction and Targeted Therapy (a Nature journal). Read more: News from Karolinska Institutet Signal …
Aktieägarna i Biocrine AB kallas härmed till årsstämma måndagen den 29 juni 2026 kl 10:00 Plats: Rolf Luft Forskningscentrum, Anna Steckséns gata 53, Solna (översta våningsplanet). Sista anmälningsdag: 2026-06-25
På Karolinska Institutets hemsida finns en nyligen publicerad artikel om att forskare vid Karolinska Institutet och KTH har utvecklat en förbättrad metod för att skapa insulinproducerande celler från mänskliga stamceller. Resultaten, som publiceras i Stem Cell Reports, visar att cellerna fungerar väl i laboratoriet och kan återställa blodsockerkontroll hos möss med diabetes. Läs mera: Nyheter från …
As has recently been published on the Karolinska Institutet in Sweden’s website, a new study led by professor Per-Olof Berggren and his colleagues shows that obesogenic diet–induced damage to the blood vessels of pancreatic islets may be long-lasting and resistant to reversal, even after returning to a healthy diet. The findings have been published in …
Aktieägarna i Biocrine AB kallas härmed till årsstämma torsdagen den 26 juni 2025 kl 11:00 Plats: Rolf Luft Forskningscentrum, Anna Steckséns gata 53, Solna (översta våningsplanet). Avstämningsdag: 2025-06-17 Sista anmälningsdag: 2025-06-23
Aktieägarna i Biocrine AB kallas härmed till årsstämma måndagen den 17 juni 2024 kl 15:00 Plats: Redeye AB, Mäster Samuelsgatan 42, våning 10 sal Dialog, Stockholm. Avstämningsdag: 2024-06-07 Sista anmälningsdag: 2024-06-12 Mer information angående årsstämman finns HÄR.
As has recently been published on the Karolinska Institutet in Sweden’s website, Professor Per-Olof Berggren and his colleagues have developed a method to study liver function and disease without requiring invasive procedures. The study is published in the journal Nature Communications. Read more: News from Karolinska Institutet Nature Communications Ögat används som fönster för att …
On the web-site of Karolinska Institutet, there is a recent press release revealing that Professor Per-Olof Berggren has been awarded a ERC Proof of Concept grant by the European Research Council (ERC). The funding will be used to advance the technology in which islets of Langerhans are transplanted into the anterior chamber of the eye …
As has recently been published on the Karolinska Institutet in Sweden’s website, Professor Per-Olof Berggren and his colleagues have brought new insight into the technology of using the anterior chamber of the eye as a servant to medical research. The relevant knowledge on the ACE technology is now being published in Physiological Reviews. Read more: …